How AI helps scientists design the next generation of medicines

Researchers are increasingly utilizing artificial intelligence to streamline the development of biologic medicines, a process traditionally characterized by high costs and frequent trial failures. By predicting the behavior of complex molecular structures, these computational tools aim to reduce the time and financial resources required to bring new therapies to clinical use.